Journal of Research & Innovation in Anesthesia

Register      Login

VOLUME 7 , ISSUE 1 ( January-June, 2022 ) > List of Articles

Original Article

A Comparative Study of Dexamethasone vs Dexmedetomidine to Attenuate Propofol-induced Intravenous Pain

Sarika S Naik, Sudhir M Naik, Saraswathi P Devi

Keywords : ASA grade 1, ASA grade 2, Dexamethasone, Dexmedetomidine, Propofol

Citation Information : Naik SS, Naik SM, Devi SP. A Comparative Study of Dexamethasone vs Dexmedetomidine to Attenuate Propofol-induced Intravenous Pain. Res Inno in Anesth 2022; 7 (1):1-4.

DOI: 10.5005/jp-journals-10049-2001

License: CC BY-NC 4.0

Published Online: 30-03-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Pain experienced by the patient while the inducing dose being given in the peripheral vein is the most common drawback of this widely used agent. Seen to vary from mild to moderate pain and complained by 2/3rd of the patients around the globe. It is among one of the high-priority outcomes which need changes during general anesthesia. Propofol is supposed to directly irritate the venous tunica intima and release nitric oxide. Propofol itself in emulsion or microemulsion form or opioid adjuvants like fentanyl, alfentanyl, remifentanyl and tramadol are tried with good results. Other agents like ketamine, ketorolac, diclofenac, flurbiprofen and combination of clonidine–ephedrine are also tried but using a larger vein and using it with lignocaine seems to be the best and easiest so far. In this randomized study, we have observed that the pain alleviation was superior in dexmedetomidine (DX) group compared to dexamethasone (DM) group, however, the drop in heart rate was significantly more in DX group, but it was treated only with a single dose of atropine in four patients. Hence dexmedetomidine can be used to attenuate the propofol-induced intravenous pain.


PDF Share
  1. Sumalatha GB, Dodawad RR, Pandarpurkar S, et al. A comparative study of attenuation of propofol-induced pain by lignocaine, ondansetron, and ramosetron. Indian J Anaesth 2016;60:25–29. DOI: 10.4103/0019-5049.174810
  2. Huang C-L, Wang Y-P, Cheng Y-J, et al. The effect of carrier intravenous fluid speed on the injection pain of propofol. Anesth Analg 1995;81(5):1087–1088. DOI: 10.1097/00000539-199511000-00033
  3. Gehan G, Karoubi P, Quinet F, et al. Optimal dose of lignocaine for preventing pain on injection of propofol. Br J Anaesth 1991;66(3): 324–326. DOI: 10.1093/bja/66.3.324
  4. Macario A, Weinger M, Truong P, et al. Which clinical anesthesia outcomes are both common and important to avoid? The perspective of a panel of expert anesthesiologists. Anesth Analg 1999;88(5): 1085–1091. DOI: 10.1097/00000539-199905000-00023
  5. Picard P, Tramèr MR, Prevention of pain on injection with propofol: a quantitative systematic review. Anesth Analg 2000;90(4):963–969. DOI: 10.1097/00000539-200004000-00035
  6. Jalota L, Kalira V, George E, et al. Prevention of pain on injection of propofol: systematic review and meta-analysis. BMJ 2011;342:d1110. DOI: 10.1136/bmj.d1110
  7. Wang H, Cork R, Rao A. Development of a new generation of propofol. Curr Opin Anaesthesiol 2007;20(4):311–315. DOI: 10.1097/ACO.0b013e3281667777
  8. King SY, Davis FM, Wells JE, et al. Lidocaine for the prevention of pain due to injection of propofol. Anesth Analg 1992;74:246–249. DOI: 10.1213/00000539-199202000-00013
  9. Vijayant GA, Tej KK, Avtar S, et al. Analgesic effect of lignocaine, tramadol, ketorolac, and ketoprofen in ameliorating propofol inducedpain. J Anesthesiol Clin Pharmacol 2005;21:389–393. DOI: 10.18410/jebmh/2019/146
  10. He L, Xu JM, He T, et al. Dexmedetomidine pretreatment alleviates propofol injection pain. Ups J Med Sci 2014;119:338–342. DOI: 10.3109/03009734.2014.941049
  11. Ambesh SP, Dubey PK, Sinha PK. Ondansetron pretreatment to alleviate pain on propofol injection: a randomized, controlled, double blinded study. Anesth Analg 1999;89:197–199. DOI: 10.1097/00000539-199907000-00035
  12. Ayoglu H, Altunkaya H, Ozer Y, et al. Does dexmedetomidine reduce the injection pain due to propofol and rocuronium? Eur J Anaesthesiol 2007;24:541–545. DOI: 10.1017/S0265021506002250
  13. Turan A, Memis D, Kaya G, et al. The prevention of pain from injection of propofol by dexmedetomidine and comparison with lidocaine. Can J Anaesth 2005;52:548–549. DOI: 10.1007/BF03016541
  14. Koo SW, Cho SJ, Kim YK, et al. Small-dose ketamine reduces the pain of propofol injection. Anesth Analg 2006;103:1444–1447. DOI: 10.1213/01.ane.0000243334.83816.53
  15. Scott RP, Sunders DA, Norman J. Propofol: Clinical strategies for preventing the pain on injection. Anaesthesia. 1988;43:492–494. DOI: 10.1111/j.1365-2044.1988.tb06641.x
  16. Lee JW, Park HJ, Choi J, et al. Comparison of ramosetron's and ondansetron's preventive anti–emetic effects in highly susceptible patients undergoing abdominal hysterectomy. Korean J Anesthesiol 2011;61:488–492. DOI: 10.4097/kjae.2011.61.6.488
  17. Mc Crirrick A, Hunter S. Pain on injection of propofol: the effect of injectate temperature. Anaesthesia 1990;45:443–444. DOI: 10.1111/j.1365-2044.1990.tb14329.x
  18. Erdivanli B, Altun M, Sezen OK, et al. Anti-nociceptive, analgesic and pathohistological effects of intrathecal dexmedetomidine and bupivacaine in rats. Rev Bras Anestesiol 2013;63:183–187. DOI: 10.1016/j.bjane.2012.02.006
  19. Kwak HJ, Min SK, Kim JS, et al. Prevention of propofol-induced pain in children: combination of alfentanil and lidocaine vs alfentanil or lidocaine alone. Br J Anaesth 2009;103:410–412. DOI: 10.1093/bja/aep163
  20. Ahmad S, De Oliveira GS Jr, Fitzgerald PC, et al. The effect of intravenous dexamethasone and lidocaine on propofol-induced vascular pain: a randomized double-blinded placebo-controlled trial. Pain Research and Treatment 2013;2013: Hindawi Publishing Corporation (article ID: 734531). DOI: 10.1155/2013/734531
  21. Patel M, Patel N, Vachchrajani P. A comparative study of attenuation of propofol induced pain by lignocaine, ondansetron, dexamethasone and cold propofol per se. Int J Sci Res 2018;8:2319-7064. DOI: 10.21275/ART201837
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.